Business Context and Reporting Period
This Form 8-K, filed on May 18, 2021, reports events occurring on May 13, 2021, for Alphatec Holdings, Inc. (ATEC). The filing details the completion of the initial phase of a public tender offer to acquire EOS imaging S.A. ("EOS"), a French medical imaging company.
Key Financial Metrics and Transaction Details
- Acquisition Status: ATEC completed the purchase of 15,815,971 EOS Shares and 2,312,074 OCEANEs (convertible bonds).
- Ownership Stake: Post-transaction, ATEC holds approximately 89.1% of outstanding EOS Shares and 57.2% of OCEANEs, representing approximately 80.0% of EOS's capital and voting rights on a fully diluted basis.
- Total Consideration: The expected total purchase price for EOS, including the reopened offer and potential squeeze-out, is approximately $116.9 million.
- Financial Statements: Specific revenue, profit, cash flow, and margin data for the period are not provided in this filing. Financial statements and pro forma information are scheduled to be filed within 71 calendar days.
Material Changes and Next Steps
The primary material change is the significant increase in ATEC's ownership of EOS following the settlement of the initial tender offer on May 13, 2021. The tender offer was reopened by the French regulator (AMF) on May 17, 2021, to purchase remaining shares and bonds at the same price, with a closing date of June 2, 2021.
If ATEC and its affiliates reach 90% or more of EOS's share capital and voting rights after the reopened offer, ATEC intends to implement a mandatory "Squeeze-Out" of remaining non-tendered shares and potentially the OCEANEs.
Guidance, Risks, and Contingencies
Management has issued forward-looking statements regarding the completion of the acquisition and the expected aggregate consideration. Key risks and contingencies include:
- Regulatory and Legal: Uncertainties regarding the AMF review, regulatory clearances, and potential litigation.
- Transaction Completion: Risks that the 90% threshold for a squeeze-out may not be met, leaving EOS shares traded on Euronext.
- Financing: The ability to secure financing on expected terms or timing.
- Operational: Challenges in integrating the businesses, retaining key personnel, and realizing synergies.
- Market Conditions: Impact of the COVID-19 pandemic and variations in market demand.
Investor Verification Checklist
- Verify the final percentage of EOS shares tendered in the reopened offer closing on June 2, 2021.
- Confirm whether the 90% threshold is met to trigger the mandatory squeeze-out.
- Review the upcoming amendment to this report (due within 71 days) for EOS's financial statements and pro forma financial information.
- Monitor for any competing offers or regulatory obstacles that could delay or terminate the transaction.
- Assess the impact of the $116.9 million total consideration on ATEC's liquidity and debt levels once financing details are finalized.